At UiPath’s Fusion London event, NFU Mutual’s automation lead explains how the UK insurer built a working agentic claims ...

UiPath (NYSE:PATH) has launched agentic AI automation solutions focused on healthcare, targeting workflows such as medical ...

UiPath (NYSE:PATH) has launched agentic AI automation tools tailored for healthcare providers and payers. The company is partnering with Genzeon to target data management and revenue cycle workflows.

It's still too early to say whether UiPath will ultimately end up, on net, as benefitting from or being harmed by AI adoption. Read why PATH stock is a Sell.

UiPath, Inc. (NYSE: PATH), a global leader in agentic automation, today announced financial results for its fourth quarter and full year fiscal 2026 ended January 31, 2026.

UiPath closes fiscal year 2026 on a high, with co-Founder and CEO Daniel Dines making a bold case that falling AI development costs are good for the automation market, not a threat to it.

Automation software company UiPath (NYSE:PATH) reported in Q4 CY2025, with sales up 13.6% year on year to $481.1 million.

AI dominance is not declared. It is operationalized, process by process, metric by metric, deployment by deployment.

A detailed overview of the challenges of benefit claims processing in the public sector, and the benefits of applying agentic automation. It highlights issues like complex eligibility criteria and ...

The department is planning to broaden its machine learning-powered Automated Decision Support tool to cover more types of claims.

UiPath develops enterprise automation technology platforms; Robotic process automation enables digital workflow transformation; UiPath software integrates artificial i ...

UiPath, Inc. (NYSE:PATH) is one of the cheap AI stocks to buy in 2026. On February 23, 2026, UiPath announced a suite of agentic AI solutions for healthcare providers and payers, targeting ...